Celldex Therapeutics Inc. (NASDAQ:CLDX) Announce Encouraging CDX-0159 Study Results In Reducing...

Max - 0

GTEH: M&A Story Gains Tangible Traction with Big Sales Projections

Max - 0

Seattle Genetics Inc. (NASDAQ:SGEN) Announce Encouraging Results Of TUKYSA Analyses In...

Max - 0

ObsEva SA (NASDAQ:OBSV) Publishes Results Of Pilot Linzagolix Study In Treatment...

Max - 0

TG Therapeutics Inc. (NASDAQ:TGTX) Reports Phase 3 GENUINE Study Results Evaluating...

Max - 0

Halozyme Therapeutics Inc. (NASDAQ:HALO) Announce That The EMA Has Approved Jannsen’s...

Max - 0

Advaxis Inc. (NASDAQ:ADXS) Provides Business Updates And Q2 2020 Financial Results

Max - 0

BioMarin Pharmaceuticals Inc. (NASDAQ:BMRN) Gives Updates Of Its Ongoing 4-Year Phase...

Max - 0

Moleculin Biotech Inc. (NASDAQ:MBRX) Submits Expansion Request For Annamycin Study Sites...

Max - 0

Novus Therapeutics Inc. (NASDAQ:NVUS) Shares Tank After OP0201 Study In Acute...

Max - 0
1...227228229...248Page 228 of 248